DAVID STEVENER: Open Payments
NPI 1609193721 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,520 in 88 payments from 16 companies in 2025. Trend: 2023 $1,476 · 2024 $1,491 · 2025 $1,520
Food & beverage: $1,520
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 29 | $333 |
| Novo Nordisk Inc | 17 | $282 |
| AstraZeneca Pharmaceuticals LP | 15 | $279 |
| Axsome Therapeutics, Inc. | 4 | $160 |
| Lilly USA, LLC | 6 | $98 |
| ABBVIE INC. | 3 | $76 |
| PFIZER INC. | 3 | $60 |
| Inspire Medical Systems, Inc. | 1 | $53 |
| Solventum Corporation | 1 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
Products named: TRELEGY ELLIPTA, Auvelity, Wegovy, AIRSUPRA, FARXIGA, VRAYLAR, MOUNJARO, Ozempic.
Industry payments across TX — which companies pay providers there.
